1,334 Views
Mickaël Aoun, MD
Head of the Infectious Diseases
Institut Jules Bordet
Brussels, Brussels Hoofdstedelijk Gewest, Belgium
Disclosure: Amplyx Pharmaceuticals (Scientific Research Study Investigator)
Sara Barbat, BSN, RN
Senior Director Clinical Operations
Amplyx Pharmaceutical
San Diego, California
Disclosure: Amplyx Pharmaceuticals (Employee)
Devra Barter, MS
Emerging Infections Epidemiologist
Colorado Department of Public Health and Environment
Denver, Colorado
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ana Belen Arauz, MD
Associate Professor of Medicine
Medicine
Hospital Santo Tomas
Birmingham, Alabama
Disclosure: Mayne Pharma (Scientific Research Study Investigator)
Ronen Ben-Ami, MD
Head of Infectious Diseases Unit
Tel Aviv Sourasky Medical Center
Tel Aviv, Tel Aviv, Israel
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Kaitlin Benedict, MPH
Epidemiologist
CDC
Atlanta, Georgia
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Pierre Bulpa, MD
Professor
ICU
Mont-Godinne University Hospital, CHU UCL Namur
Yvoir, Namur, Belgium
Disclosure: Amplyx Pharmaceuticals (Scientific Research Study Investigator)
Tom Chiller, MD, MPHTM
Chief, Mycotic Diseases Branch
Centers for Disease Control and Prevention
Atlanta, Georgia
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Benjamin Colton, PharmD
Clinical Pharmacy Specialist
National Institutes of Health
Bethesda, Maryland
Disclosure: Merck (Shareholder)Pfizer (Shareholder)
Li Deng, PhD
Mathematical Statistician
Centers for Disease Control and Prevention
Atlanta, Georgia
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Gordana Derado, PhD
Statistician
CDC
Atlanta, Georgia
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Monica Farley, MD
Professor
Infectious Diseases
Emory University
Atlanta, Georgia
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Elise Ferre, PA-C, MPH
Physician Assistant
NIAID
Bethesda, Maryland
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ricard Ferrer, MD, PhD
Critical Care physician
Vall d’Hebron University Hospital
Barcelona, Catalonia, Spain
Disclosure: Shionogi B.V. (Advisor or Review Panel member)
Jill Fischer, MT/ASCP
Bacteriology Laboratory Specialist
Minnesota Department of Health
St. Paul, Minnesota
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Alexandra Freeman, MD
Senior clinician
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Anita Gellert, BSN
Ms
University of Rochester
Rochester, New York
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Lee Harrison, MD
Head, Infectious Diseases Epidemiology Research Unit
University of Pittsburgh
Pittsburgh, Pennsylvania
Disclosure: GSK: Consultant; Merck: Consultant; Pfizer: Consultant; Sanofi Pasteur: Consultant
Justin Hayes, M.D.
Assistant Professor, Medicine, Division of Infectious Diseases
University of Arizona College of Medicine
Tucson, Arizona
Disclosure: Mayne Pharma (Grant/Research Support)
Michael Hodges, BSc. MD
Chief Medical Officer
Amplyx Pharmaceuticals
San Diego, California
Disclosure: Amplyx Pharmaceuticals Inc. (Employee)
Brendan Jackson, MD, MPH
Medical Epidemiologist
Mycotic Diseases Branch
Centers for Disease Control and Prevention
Atlanta, Georgia
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Helen Johnston, MPH
Emerging Infections Unit Manager
Colorado Department of Public Health and Environment
Denver, Colorado
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Bart Jan Kullberg, M.D., FRCP, FIDSA
Professor of Medicine and Infectious Diseases
Radboud univerity medical center
Nijmegen, Gelderland, Netherlands
Disclosure: Amplyx (Advisor or Review Panel member)
Michail Lionakis, MD, ScD
Chief, Fungal Pathogenesis Section, Laboratory of Clinical Immunology & Microbiology
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland
Disclosure: Matinas BioPharma (Research Grant or Support)
Ruying Lu, n/a
Senior Director
Matinas BioPharma Inc.
Bridgewater, New Jersey
Disclosure: Matinas BioPharma Inc. (Employee)Matinas BioPharma Inc. (Employee, Shareholder)
Meghan Lyman, MD
Medical Epidemiologist
Mycotic Diseases Branch
CDC
Atlanta, Georgia
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Raphael Mannino, PhD
Chief Scientific Officer
Matinas BioPharma, Inc.
Bridgewater, New Jersey
Disclosure: Matinas BioPharma Inc. (Employee, Shareholder)
Kaytlynn Marceaux, MPH
research assistant
Johns Hopkins University
Baltimore, Maryland
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Theresa Matkovits, Ph.D.
Chief Development Officer
Matinas BioPharma
Bedminster, New Jersey
Disclosure: Matinas BioPharma (Employee, Shareholder)
Todd McCarty, MD
Assistant Professor
University of Alabama at Birmingham; Birmingham VA Medical Center
Birmingham, Alabama
Disclosure: Amplyx (Scientific Research Study Investigator)Cidara (Scientific Research Study Investigator)
Gerald McGwin, M.S., Ph.D.
Professor
Epidemiology
University of Alabama at Birmingham
Birmingham, Alabama
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Rachel McMullen, MS
Research Assistant
University of Alabama at Birmingham
Birmingham, Alabama
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Marisa Miceli, MD, FIDSA
Associate Professor
Division of Infectious Diseases
University of Michigan
Ann Arbor, Michigan
Disclosure: SCYNEXIS, Inc. (Advisor or Review Panel member)
Mary Moore, MBA
Research Assistant
University of Alabama at Birmingham
Birmingham, Alabama
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Joelle Nadle, MPH
Project Coordinator
California Emerging Infections Program
Oakland, California
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Iwonka Oborska, PhD
Independent consultant
Amplyx
Horsham, England, United Kingdom
Disclosure: Amplyx Pharmaceuticals (Consultant, Independent Contractor)
Ilana Oren, MD
head of transplant infectious diseases
RHCC
Kiryat Motzkin, Hefa, Israel
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Brittany Pattee, MPH
Epidemiologist
Minnesota Department of Health
St. Paul, Minnesota
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Alisa Peinhardt, MAIS, BSN
Program Manager - Infectious Disease Clinical Trials Group
Division of Infectious Disease
University of Alabama at Birmingham
Birmingham, Alabama
Disclosure: Mycoses Study Group Education and Research Consortium (Consultant)
Erin Phipps, DVM, MPH
Principal Investigator, CDI/MuGSI/Candidemia Surveillance
New Mexico Emerging Infections Program
University of New Mexico
Albuquerque, New Mexico
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Laurie Proia, MD
Assistant Professor
Rush Medical College
Chicago, Illinois
Disclosure: Mayne Pharma (Scientific Research Study Investigator)
Galia Rahav, MD
Head of Infectious Disease Unit
Infectious Disease Unit
Sheba Medical Center and Tel Aviv University
Ramat Gan, HaMerkaz, Israel
Disclosure: AstraZeneca (Scientific Research Study Investigator)
William Schaffner, MD
Professor of Preventive Medicine
Vanderbilt University
Nashville, Tennessee
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sarah Shrum, MPH
coordinator
New Mexico Emerging Infectious Program
Albuquerque, New Mexico
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Andrej Spec, MD, MSCI
Assistant Professor
Washingotn University In St Louis, School of Medicine
St. Louis, Missouri
Disclosure: Mayne (Consultant, Grant/Research Support)
Doris Swaim, RN, BSN, CCRC
Nurse protocol coordinator
NIAID/LIR
Leidos Biomedical Research
Bethesda, Maryland
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
George R. Thompson, MD
Associate Professor of Medicine
Infectious Diseases
UC-Davis
Sacramento, California
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Tristan Timbrook, PharmD
Adjunct Instructor
University of Utah College of Pharmacy
Salt Lake City, Utah
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Edmund Tramont, MD
Assoc. Dir Special Projects DCR/NIAID/NIH
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Brandon Tritle, PharmD, BCIDP
Clinical Pharmacist
University of Utah Health
Salt Lake City, Utah
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Amanda Urban, DNP, CRNP
Nurse Practitioner
Leidos Biomedical Research
Bethesda, Maryland
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jose Vazquez, MD, FIDSA
Professor of Medicine
Internal Medicine
Medical College of Georgia at Augusta University
Augusta, Georgia
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Pamela Wedel, BSc
Vice President, Clinical Operations
Clinical Operations
Amplyx Pharmaceuticals
La Mesa, California
Disclosure: Amplyx Pharmaceuticals (Employee)
Alexia Zhang, MPH
Epidemiologist
Oregon Public Health Division-Acute and Communicable Disease Prevention
Portland, Oregon
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jigar Desai, PhD
Research Fellow
Fungal Pathogenesis Section, National Institutes of Allergy and Infectious Diseases, National Institutes of Health
Bethesda, MD
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Andre Hejazi, BS
PharmD Student
University of Utah College of Pharmacy
Salt Lake City, Utah
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Peter Pappas, MD
Professor of Medicine
Medicine
University of Alabama at Birmingham
Birmingham, Alabama
Disclosure: Amplyx : Advisor or Review Panel member (Status: Ongoing); Astellas : Grant/Research Support (Status: Ongoing), Scientific Research Study Investigator (Status: Ongoing); Cidara : Advisor or Review Panel member (Status: Ongoing), Scientific Research Study Investigator (Status: Ongoing); F2G : Advisor or Review Panel member (Status: Ongoing); Mayne Pharma : Scientific Research Study Investigator; Merck : Grant/Research Support (Status: Ongoing); Scynexis : Consultant (Status: Ongoing), Grant/Research Support (Status: Ongoing)
Brenda Tesini, MD
Assistant Professor
New York Emerging Infections Program
University of Rochester
Rochester, NY
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Mitsuru Toda, PhD
Epidemiologist
Centers for Disease Control and Prevention
Atlanta, GA
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.